Mahdi Garelnabi to Proprotein Convertase 9
This is a "connection" page, showing publications Mahdi Garelnabi has written about Proprotein Convertase 9.
Connection Strength
0.759
-
Ochin CC, Garelnabi M. Berberine Encapsulated PLGA-PEG Nanoparticles Modulate PCSK-9 in HepG2 Cells. Cardiovasc Hematol Disord Drug Targets. 2018; 18(1):61-70.
Score: 0.570
-
Punch E, Klein J, Diaba-Nuhoho P, Morawietz H, Garelnabi M. Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis. J Am Heart Assoc. 2022 02; 11(3):e023328.
Score: 0.189